Fast Titration in the treatment of Schizophrenia, Taiwan
Study identifier:D1449C00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Fast titration of quetiapine versus conventional titration in the treatment of schizophrenia/schizoaffective disorder: a randomised, parallel group open trial
Medical condition
schizophrenia
Phase
Phase 3
Healthy volunteers
No
Study drug
Quetiapine fumarate
Sex
All
Actual Enrollment
40
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Aug 2004
Primary Completion Date: -
Study Completion Date: 01 Apr 2006
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Mar 2009 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Taiwan Medical Director
AstraZeneca
